NL7405114A - - Google Patents

Info

Publication number
NL7405114A
NL7405114A NL7405114A NL7405114A NL7405114A NL 7405114 A NL7405114 A NL 7405114A NL 7405114 A NL7405114 A NL 7405114A NL 7405114 A NL7405114 A NL 7405114A NL 7405114 A NL7405114 A NL 7405114A
Authority
NL
Netherlands
Application number
NL7405114A
Other versions
NL178564C (nl
NL178564B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7405114A publication Critical patent/NL7405114A/xx
Publication of NL178564B publication Critical patent/NL178564B/nl
Application granted granted Critical
Publication of NL178564C publication Critical patent/NL178564C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7405114,A 1973-04-17 1974-04-16 Werkwijze voor het bereiden van farmaceutische preparaten op basis van 1-gesubstitueerde pyrazolon-5-derivaten. NL178564C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2319278A DE2319278C2 (de) 1973-04-17 1973-04-17 Pharmazeutisches Mittel

Publications (3)

Publication Number Publication Date
NL7405114A true NL7405114A (nl) 1974-10-21
NL178564B NL178564B (nl) 1985-11-18
NL178564C NL178564C (nl) 1986-04-16

Family

ID=5878313

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7405114,A NL178564C (nl) 1973-04-17 1974-04-16 Werkwijze voor het bereiden van farmaceutische preparaten op basis van 1-gesubstitueerde pyrazolon-5-derivaten.

Country Status (11)

Country Link
US (2) US4018890A (nl)
BE (1) BE813745A (nl)
DE (1) DE2319278C2 (nl)
FR (1) FR2226169B1 (nl)
GB (1) GB1434171A (nl)
IE (1) IE39211B1 (nl)
IL (1) IL44625A (nl)
LU (1) LU69870A1 (nl)
NL (1) NL178564C (nl)
PH (1) PH10818A (nl)
ZA (1) ZA742383B (nl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2427272C3 (de) 1974-06-06 1981-10-01 Bayer Ag, 5090 Leverkusen 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
CA1229553A (en) * 1983-05-18 1987-11-24 Edmund Y. Lukevits Pharmaceutical preparation for the treatment of hypertensive disease and myocardial infarction
DE3436383A1 (de) * 1984-10-04 1986-04-10 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von pyrazolonderivaten
DK169672B1 (da) * 1985-05-20 1995-01-09 Mitsubishi Chem Ind Farmaceutiske præparater indeholdende pyrazolonderivater som aktiv bestanddel og anvendelsen af pyrazolonderivater til fremstilling af farmaceutiske præparater
USRE35801E (en) * 1985-05-20 1998-05-19 Mitsubishi Chemical Corporation Prophylactic and therapeutic composition for circulatory disorders and method of treatment
DE3626908A1 (de) * 1986-08-08 1988-02-11 Bayer Ag Parenterale loesung
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
US9573122B2 (en) * 2014-08-29 2017-02-21 Chevron U.S.A. Inc. Small crystal LTL framework type zeolites
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147276A (en) * 1964-09-01 Pyrazolones
US2376380A (en) * 1945-05-22 Preparation of amino pyrazolones
US2476986A (en) * 1949-07-26 Elmobe louis martin
US2476987A (en) * 1949-07-26 S-acyloxy pyrazqles and method foe
GB559919A (en) * 1942-09-07 1944-03-10 Lamson Engineering Co Improvements in and relating to pneumatic tube conveyor systems
GB636988A (en) * 1947-12-24 1950-05-10 Gevaert Photo Producten Naamlo Improvements in and relating to the production of colour photographic images
US2511231A (en) * 1949-03-26 1950-06-13 Eastman Kodak Co 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography
US2600788A (en) * 1949-06-07 1952-06-17 Eastman Kodak Co Halogen-substituted pyrazolone couplers for color photography
ZA10401B (nl) * 1949-08-22
US2672417A (en) * 1949-12-31 1954-03-16 Gevaert Photo Prod Nv Production of color photographic images
GB779703A (en) * 1953-07-06 1957-07-24 Hoechst Ag Pyrazolone compounds and a process for making them
US2848446A (en) * 1954-02-23 1958-08-19 Saul & Co Azo dyestuffs
DE1003215B (de) * 1954-08-07 1957-02-28 Hoechst Ag Verfahren zur Herstellung von 1-Benzyl-3-methyl-pyrazolon-(5)
US3014916A (en) * 1959-01-22 1961-12-26 May & Baker Ltd Pyrazole derivatives
GB935538A (en) * 1959-04-06 1963-08-28 Stop Motion Devices Corp Stop-motion head for use on knitting machines
GB961037A (en) * 1960-08-23 1964-06-17 Smith & Nephew Pyrazolones and processes for their preparation
NL279140A (nl) * 1961-05-31
US3190888A (en) * 1963-08-22 1965-06-22 American Home Prod Aryloxyalkylpyrazole
DE1670529C3 (de) * 1966-07-13 1974-01-10 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Substituierte s-Triazine
GB1190914A (en) * 1966-09-26 1970-05-06 Agfa Gevaert Nv 2-Pyrazolin-5-Ones and the use thereof as Colour Couplers
FR1558513A (nl) * 1968-01-04 1969-02-28
GB1247688A (en) * 1968-02-26 1971-09-29 Agfa Gevaert Monomeric and polymeric 2-pyrazoline-5-one colour couplers
JPS4818858B1 (nl) * 1969-04-07 1973-06-08
FR2068413A1 (en) * 1969-10-22 1971-08-27 Synthelabo 1-alkyl-3-alkylamino-5-aryl-pyrazolines hypo-and hypertensives
US3615506A (en) * 1970-02-09 1971-10-26 Eastman Kodak Co Silver halide emulsions containing 3-cyclicamino-5-pyrazolone color couplers
US3694456A (en) * 1970-05-08 1972-09-26 Takeda Chemical Industries Ltd 1-disubstituted aminopyrazoles
FR2101060B1 (nl) * 1970-08-14 1974-02-01 Roussel Uclaf
FR2104931B1 (nl) * 1970-09-08 1975-01-10 Ferlux
JPS5417772B1 (nl) * 1970-12-04 1979-07-03
JPS548689B1 (nl) * 1970-12-04 1979-04-18
DE2230792A1 (de) * 1972-06-23 1974-01-17 Bayer Ag 3-amino-pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2230675A1 (de) * 1972-06-23 1974-01-10 Bayer Ag Diuretisches und antihypertensives mittel
AR207445A1 (es) * 1973-04-17 1976-10-08 Bayer Ag Procedimiento de preparacion de nuevos derivados de pirazolonas-(5)-1-substituidas

Also Published As

Publication number Publication date
LU69870A1 (nl) 1974-11-21
PH10818A (en) 1977-09-08
US4288446A (en) 1981-09-08
GB1434171A (en) 1976-05-05
DE2319278A1 (de) 1974-11-07
US4018890A (en) 1977-04-19
IE39211L (en) 1974-10-17
DE2319278C2 (de) 1986-02-20
AU6793474A (en) 1975-10-16
IL44625A0 (en) 1974-06-30
BE813745A (fr) 1974-10-16
ZA742383B (en) 1975-04-30
USB459408I5 (nl) 1976-03-23
IL44625A (en) 1978-07-31
NL178564C (nl) 1986-04-16
FR2226169B1 (nl) 1978-07-28
NL178564B (nl) 1985-11-18
FR2226169A1 (nl) 1974-11-15
IE39211B1 (en) 1978-08-30

Similar Documents

Publication Publication Date Title
AR201758A1 (nl)
AR201235Q (nl)
AR201231Q (nl)
AU474593B2 (nl)
AU474838B2 (nl)
FR2226169B1 (nl)
AU450229B2 (nl)
AR201229Q (nl)
AU6923174A (nl)
AR199451A1 (nl)
FR2226170B1 (nl)
AR210729A1 (nl)
AR193950A1 (nl)
AR196382A1 (nl)
AR197627A1 (nl)
AR195311A1 (nl)
AU447540B2 (nl)
AR200256A1 (nl)
AR200885A1 (nl)
AR195948A1 (nl)
AU5288973A (nl)
AR196212Q (nl)
AR196123Q (nl)
AU1891376A (nl)
BG19441A1 (nl)

Legal Events

Date Code Title Description
BC A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee